Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer
Linfeng Xian, Pei Zhao, Xi Chen, et al.
Cellular Oncology (2022) Vol. 45, Iss. 5, pp. 1019-1036
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Organoids: The current status and biomedical applications
Siqi Yang, Hai‐Jie Hu, Heng‐Chung Kung, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 106
Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology
Shuyi Ji, Feng Li, Zile Fu, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 706
Closed Access | Times Cited: 62
Disulfidptosis-related lncRNA signatures assess immune microenvironment and drug sensitivity in hepatocellular carcinoma
Kequan Xu, Caixia Dai, Jialing Yang, et al.
Computers in Biology and Medicine (2024) Vol. 169, pp. 107930-107930
Closed Access | Times Cited: 21
State-of-the-Art Liver Cancer Organoids: Modeling Cancer Stem Cell Heterogeneity for Personalized Treatment
Julien Giron‐Michel, Maël Padelli, Estelle Oberlin, et al.
BioDrugs (2025)
Open Access | Times Cited: 1
Advances, challenges and future applications of liver organoids in experimental regenerative medicine
Da Gong, Jian Mo, Mei Zhi Zhai, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access | Times Cited: 1
Toward reproducible tumor organoid culture: focusing on primary liver cancer
Lianming Guo, Chao Li, Weiqiang Gong
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine
Qigu Yao, Sheng Cheng, Qiaoling Pan, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 8
Overexpression of Aurora Kinase B Is Correlated with Diagnosis and Poor Prognosis in Hepatocellular Carcinoma
Jin Zhang, Jiaxiu Ma, Yalan Li, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2199-2199
Open Access | Times Cited: 6
Drug resistance in human cancers — Mechanisms and implications
Sudikshaa Vijayakumar, Raveena Dhakshanamoorthy, Akshaya Baskaran, et al.
Life Sciences (2024) Vol. 352, pp. 122907-122907
Closed Access | Times Cited: 6
Organoids in the oral and maxillofacial region: present and future
Yufei Wu, Xiangyang Li, Hanzhe Liu, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Precision models in hepatocellular carcinoma
Marina Bárcena‐Varela, Satdarshan P. Monga, Amaia Lujambio
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 22, Iss. 3, pp. 191-205
Closed Access | Times Cited: 4
circGLS2 inhibits hepatocellular carcinoma recurrence via regulating hsa-miR-222-3p–PTEN–AKT signaling
Xi Chen, Ting Wu, Linfeng Xian, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 10
Epidemiological characteristics and precise prophylaxis and control of HBV-associated primary liver cancer
Yuqi Feng, Letian Fang, Guangwen Cao
Hepatoma Research (2025)
Open Access
Mesenchymal Stem Cell-Derived Exosomes in Cancer Resistance Against Therapeutics
Vignesh Balaji E, Keerthilatha M. Pai, K. Sreedhara Ranganath Pai
Cancers (2025) Vol. 17, Iss. 5, pp. 831-831
Open Access
Harnessing the Power of Traditional Chinese Medicine in Cancer Treatment: The Role of Nanocarriers
Zhongheng Fu, Shengmei Wang, Xin Zhou, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 3147-3174
Open Access
Differences in chemotherapeutic drug sensitivity before and after patient-derived tumor organoid construction
Fang Shao, Xin Huang, Zhihong Ma, et al.
Toxicology and Applied Pharmacology (2025), pp. 117340-117340
Closed Access
Opportunities and challenges of hepatocellular carcinoma organoids for targeted drugs sensitivity screening
Cuiying Xie, Ancheng Gu, Muhammad Khan, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 9
Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening
H. Fang, Haoying Xu, Jiong Yu, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 794-794
Open Access | Times Cited: 3
Hepatocellular-Carcinoma-Derived Organoids: Innovation in Cancer Research
Carlo Airola, Maria Pallozzi, Eleonora Cesari, et al.
Cells (2024) Vol. 13, Iss. 20, pp. 1726-1726
Open Access | Times Cited: 3
The combined characteristics of cholesterol metabolism and the immune microenvironment may serve as valuable biomarkers for both the prognosis and treatment of hepatocellular carcinoma
Weiyu Bai
Heliyon (2023) Vol. 9, Iss. 12, pp. e22885-e22885
Open Access | Times Cited: 7
Patient-Derived Organoids on a Microarray for Drug Resistance Study in Breast Cancer
Tianyuan Fang, Xinlun Xie, Wei Lü, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 46, pp. 18384-18391
Closed Access | Times Cited: 2
Updates on Organoid Model for the Study of Liver Cancer
Korri Elvanita El-Khobar, Caecilia Sukowati
Technology in Cancer Research & Treatment (2023) Vol. 22
Open Access | Times Cited: 5
SNHG1, interacting with SND1, contributes to sorafenib resistance of liver cancer cells by increasing m6A‐mediated SLC7A11 expression and promoting aerobic glycolysis
Rong Li, Shunle Li, Lin Shen, et al.
Environmental Toxicology (2023) Vol. 39, Iss. 3, pp. 1269-1282
Closed Access | Times Cited: 4
The crosstalk between cellular survival pressures and N6-methyladenosine modification in hepatocellular carcinoma
Chu‐Li Fu, Zhengwei Zhao, Qiangnu Zhang
Hepatobiliary & pancreatic diseases international (2024)
Closed Access | Times Cited: 1
Organoid as a promising tool for primary liver cancer research: a comprehensive review
Xuekai Hu, Jiayun Wei, Pinyan Liu, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top